Home › pSivida Corp. (PSDV) Upgraded to "Hold" at Zacks Investment Research
 

Keywords :   


pSivida Corp. (PSDV) Upgraded to "Hold" at Zacks Investment Research

2016-01-02 14:07:55| Biotech - Topix.net

According to Zacks, "pSivida Corp., a specialty pharmaceutical company, combines existing drugs with its sustained release delivery technologies to develop transformational products primarily in ophthalmology. pSivida's two proprietary technology systems are Durasert and Tethadur.

Tags: research hold investment corp

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Atlantic Tropical Weather Outlook
05.10Tropical Storm Milton Update Statement
05.10Summary for Tropical Storm Milton (AT4/AL142024)
05.10Eastern North Pacific Tropical Weather Outlook
05.10Tropical Depression Fourteen Graphics
05.10Tropical Depression Fourteen Forecast Discussion Number 1
05.10Tropical Depression Fourteen Wind Speed Probabilities Number 1
05.10Tropical Depression Fourteen Public Advisory Number 1
More »